Clinical data | |
---|---|
Other names | U-7265; 5α-Dihydrofluoxymesterone; 9α-Fluoro-11β-hydroxy-17α-methyl-5α-dihydrotestosterone; 9α-Fluoro-11β-hydroxy-17α-methyl-5α-DHT; 9α-Fluoro-11β-hydroxy-17α-methyl-5α-androstan-17β-ol-3-one |
Routes of administration | By mouth |
Drug class | Androgen; Anabolic steroid |
Chemical and physical data | |
Formula | C20H30FO3 |
Molar mass | 337.455 g·mol−1 |
3D model ( JSmol) | |
| |
|
Dihydrofluoxymesterone (developmental code name U-7265) is an androgen and anabolic steroid (AAS) which was never marketed. [1] [2] [3] It was assessed in the treatment of breast cancer in women in at least one clinical study in the 1970s and showed effectiveness similar to that of other AAS. [1] [2] The drug is the 5α-reduced analogue and metabolite of fluoxymesterone. [1] [2] [3]